Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Gurbel

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Pharmacology|October 1, 1996
Intracoronary magnesium and diltiazem affect to a similar extent certain hemostatic factors during acute myocardial infarction in swineV L Serebruany, M L Schlossberg, L R Edenbaum, et al.
Journal of Cardiovascular Pharmacology|December 1, 1996
Hemostatic changes after early versus late intracoronary magnesium during acute myocardial infarction in swineV L Serebruany, W R Herzog, M L Schlossberg, et al.
International Journal of Cardiology|August 29, 1997
Effects of intracoronary diltiazem on certain hemostatic parameters during acute myocardial infarction in swineV L Serebruany, M L Schlossberg, L R Edenbaum, et al.
Chest|November 1, 1994
Pharmacomechanical thrombolysis of experimental pulmonary emboli. Rapid low-dose intraembolic therapyV F Tapson, P A Gurbel, L A Witty, et al.
Pharmacological Research|October 23, 1998
Serial changes of soluble endothelin-1 levels during myocardial ischaemia-reperfusion. Effects of magnesium, diltiazem and a novel MAC-1 inhibitorV L Serebruany, M L Schlossberg, L R Edenbaum, et al.
Journal of Thrombosis and Thrombolysis|September 27, 2000
Effect of coronary thrombolysis on the plasma concentration of osteonectin (SPARC, BM40) in patients with acute myocardial infarctionV L Serebruany, D Atar, S R Murugesan, et al.
Cardiology|August 7, 1998
Antecedent aspirin therapy inhibits baseline platelet activity in patients presenting with acute myocardial infarction. The GUSTO-III Platelet SubstudyV L Serebruany, R D Bahr, C M O'Connor, et al.
Pharmacology|August 1, 1996
Mac-1 inhibitor affects certain hemostatic parameters during myocardial stunning in swineV L Serebruany, S R Solomon, L R Edenbaum, et al.
American Heart Journal|October 2, 2001
Uniform platelet activation exists before coronary stent implantation despite aspirin therapyV L Serebruany, C C Cummings, A I Malinin, et al.
American Heart Journal|September 15, 1998
Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarctionV L Serebruany, P A Gurbel, A R Shustov, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Pharmacology|October 1, 1996
Intracoronary magnesium and diltiazem affect to a similar extent certain hemostatic factors during acute myocardial infarction in swineV L Serebruany, M L Schlossberg, L R Edenbaum, et al.
Journal of Cardiovascular Pharmacology|December 1, 1996
Hemostatic changes after early versus late intracoronary magnesium during acute myocardial infarction in swineV L Serebruany, W R Herzog, M L Schlossberg, et al.
International Journal of Cardiology|August 29, 1997
Effects of intracoronary diltiazem on certain hemostatic parameters during acute myocardial infarction in swineV L Serebruany, M L Schlossberg, L R Edenbaum, et al.
Chest|November 1, 1994
Pharmacomechanical thrombolysis of experimental pulmonary emboli. Rapid low-dose intraembolic therapyV F Tapson, P A Gurbel, L A Witty, et al.
Pharmacological Research|October 23, 1998
Serial changes of soluble endothelin-1 levels during myocardial ischaemia-reperfusion. Effects of magnesium, diltiazem and a novel MAC-1 inhibitorV L Serebruany, M L Schlossberg, L R Edenbaum, et al.
Journal of Thrombosis and Thrombolysis|September 27, 2000
Effect of coronary thrombolysis on the plasma concentration of osteonectin (SPARC, BM40) in patients with acute myocardial infarctionV L Serebruany, D Atar, S R Murugesan, et al.
Cardiology|August 7, 1998
Antecedent aspirin therapy inhibits baseline platelet activity in patients presenting with acute myocardial infarction. The GUSTO-III Platelet SubstudyV L Serebruany, R D Bahr, C M O'Connor, et al.
Pharmacology|August 1, 1996
Mac-1 inhibitor affects certain hemostatic parameters during myocardial stunning in swineV L Serebruany, S R Solomon, L R Edenbaum, et al.
American Heart Journal|October 2, 2001
Uniform platelet activation exists before coronary stent implantation despite aspirin therapyV L Serebruany, C C Cummings, A I Malinin, et al.
American Heart Journal|September 15, 1998
Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarctionV L Serebruany, P A Gurbel, A R Shustov, et al.
Pageof 8